Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Guide7 min read

Is Sprout Legit? An Honest Audit (2026)

Sprout sells compounded semaglutide from $99/month on a 12-month plan, with 2-day fulfillment and a brand-name Wegovy option. We audited the fine print.

Updated September 24, 2026

Medically reviewed on

How we review

Key takeaways

  • Sprout passes the clinical test: an online medical intake reviewed by a licensed provider, prescription medication only, and shipping within 2 days of approval.
  • Published prices (verified November 3, 2026): compounded semaglutide from $99/month and tirzepatide from $149/month on the 12-month plan ($149 and $199 month to month), brand-name Wegovy from $1,799/month.
  • Choosing Sprout trades a longer track record for speed, personalization and the Wegovy option; risk-averse buyers may prefer a longer-established provider.

The audit has to work differently for a newer brand

The short answerYes. Sprout passes the clinical test, with an online medical intake reviewed by a licensed provider, prescription medication only and shipping within two days of approval, and its published prices are clear: compounded semaglutide from $99 a month and tirzepatide from $149 on the 12-month plan ($149 and $199 month to month), brand-name Wegovy from $1,799.

Sprout is a newer brand, so the honest audit runs on two tests: does the clinical process have a real gate, and do the published prices survive contact with the checkout page?

Sprout passes the first test the way every legitimate telehealth provider does: an online medical intake reviewed by a licensed provider who decides whether GLP-1 treatment is appropriate. Prescription medication only - there's no "skip the doctor" path, which is exactly what you want to see. If prescribed, the medication ships within 2 days of approval.

Does Sprout's pricing hold at checkout?

Sprout's published structure is simple: compounded semaglutide from $99/month on the 12-month plan ($1,188 billed upfront), $110 on the 6-month plan, $125 on the 3-month plan and $149 month to month; compounded tirzepatide from $149/month on the same ladder ($160, $180 and $199); and - genuinely unusual for a mid-tier provider - brand-name Wegovy from $1,799/month. The price is the same at any dose, there's no membership fee, and plans renew until cancelled - you can cancel any time before the next refill. No teaser rate that balloons after month one; the trade-off is commitment, since the lowest rates need the longer plans and the 12-month plan is billed upfront.

If the pros outweigh the cons for you, the intake is the next step. Start Sprout's online intake → (opens Sprout’s site)

Shop Sprout's GLP-1 plans

Sprout's published plans - conditions shown under each price.

Sprout at a glance

The same card, verified pricing and ratings as our full comparison.

Sprout logo

Very Good

8.2out of 10

Save $200 on your first month

Ships within 2 daysPersonalized treatment plans
  • Compounded semaglutide from $99/mo (12-month plan; $149/mo month to month)
  • Compounded tirzepatide from $149/mo (12-month plan; $199/mo month to month)
  • Brand-name Wegovy available (from $1,799/mo)
  • Prescriptions shipped within 2 days

from $99/month

Personalized GLP-1 telehealth program - compounded semaglutide from $99/month and tirzepatide from $149/month on a 12-month plan, with brand-name Wegovy also on the shelf - and prescriptions shipped within 2 days.

Read full Sprout review

So - is Sprout legit?

Yes, with the caveats stated plainly: licensed-provider review before any prescription, published prices that hold, and 2-day fulfillment. What it can't yet offer is a long track record - it is a newer brand with no million-patient claim - so risk-averse buyers may prefer a longer-established provider. If you go with Sprout, you're trading track record for speed, personalization and the Wegovy option.

→ Read the full Sprout review: plans and pricing

→ How Sprout stacks up against embody's $49 flat price

This article is general information, not medical advice.

Prefer to see Sprout for yourself before reading on? Open Sprout's eligibility check → (opens Sprout’s site)

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)